Flavio Ballante

Dr. Flavio Ballante

Uppsala University, Department of Cell and Molecular Biology
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Pharmacological Reviews
Verified
Journal Article
Open access
PDF file
Flavio BallanteFlavio Ballante
Flavio Ballante
AKAlbert J. Kooistra
Albert J. Kooistra
SKStefanie Kampen
Stefanie Kampen
CGChris de Graaf
Chris de Graaf
JCJens Carlsson
Jens Carlsson
G protein–coupled receptors (GPCRs) constitute the largest family of membrane proteins in the human genome and are important therapeutic targets. During the last decade, the number of atomic-resolution structures of GPCRs has increased rapidly, providing insights into drug binding at the molecular level. These breakthroughs have created excitement regarding the potential of using structural information in ligand design and initiated a new era of rational drug discovery for GPCRs. The molecular docking method is now widely applied to model the three-dimensional structures of GPCR-ligand complexes and screen for chemical probes in large compound libraries. In this review article, we first summarize the current structural coverage of the GPCR superfamily and the understanding of receptor-ligand interactions at atomic resolution. We then present the general workflow of structure-based virtual screening and strategies to discover GPCR ligands in chemical libraries. We assess the state of the art of this research field by summarizing prospective applications of virtual screening based on experimental structures. Strategies to identify compounds with specific efficacy and selectivity profiles are discussed, illustrating the opportunities and limitations of the molecular docking method. Our overview shows that structure-based virtual screening can discover novel leads and will be essential in pursuing the next generation of GPCR drugs. Significance Statement Extraordinary advances in the structural biology of G protein–coupled receptors have revealed the molecular details of ligand recognition by this large family of therapeutic targets, providing novel avenues for rational drug design. Structure-based docking is an efficient computational approach to identify novel chemical probes from large compound libraries, which has the potential to accelerate the development of drug candidates.

18 March 2025 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
ZTZiaurrehman Tanoli
Ziaurrehman Tanoli
AFAdrià Fernández-Torras
Adrià Fernández-Torras
UÖUmut Onur Özcan
Umut Onur Özcan
AKAleksandr Kushnir
Aleksandr Kushnir
KNKristen Michelle Nader
Kristen Michelle Nader
TATero Aittokallio
Tero Aittokallio

6 January 2016 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
Flavio BallanteFlavio Ballante
Flavio Ballante
GMGarland R. Marshall
Garland R. Marshall

1 May 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EPEnrico Perspicace
Enrico Perspicace
VJValérie Jouan-Hureaux
Valérie Jouan-Hureaux
Rino RagnoRino Ragno
Rino Ragno
Flavio BallanteFlavio Ballante
Flavio Ballante
SSStefania Sartini
Stefania Sartini
SHStéphanie Hesse
Stéphanie Hesse

13 May 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
JKJon Kapla
Jon Kapla
IEIsmael Rodríguez Espigares
Ismael Rodríguez Espigares
Flavio BallanteFlavio Ballante
Flavio Ballante
JSJana Selent
Jana Selent
JCJens Carlsson
Jens Carlsson
The determination of G protein-coupled receptor (GPCR) structures at atomic resolution has improved understanding of cellular signaling and will accelerate the development of new drug candidates. However, experimental structures still remain unavailable for a majority of the GPCR family. GPCR structures and their interactions with ligands can also be modelled computationally, but such predictions have limited accuracy. In this work, we explored if molecular dynamics (MD) simulations could be used to refine the accuracy ofin silicomodels of receptor-ligand complexes that were submitted to a community-wide assessment of GPCR structure prediction (GPCR Dock). Two simulation protocols were used to refine 30 models of the D3dopamine receptor (D3R) in complex with an antagonist. Close to 60 μs of simulation time was generated and the resulting MD refined models were compared to a D3R crystal structure. In the MD simulations, the receptor models generally drifted further away from the crystal structure conformation. However, MD refinement was able to improve the accuracy of the ligand binding mode. The best refinement protocol improved agreement with the experimentally observed ligand binding mode for a majority of the models. Receptor structures with improved virtual screening performance, which was assessed by molecular docking of ligands and decoys, could also be identified among the MD refined models. Application of weak restraints to the transmembrane helixes in the MD simulations further improved predictions of the ligand binding mode and second extracellular loop. These results provide guidelines for application of MD refinement in prediction of GPCR-ligand complexes and directions for further method development.

13 June 2012 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
Flavio BallanteFlavio Ballante
Flavio Ballante
Rino RagnoRino Ragno
Rino Ragno